Literature DB >> 28418732

Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.

Gregory P Forlenza1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28418732      PMCID: PMC5583547          DOI: 10.1089/dia.2017.0048

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


× No keyword cloud information.
  26 in total

1.  Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.

Authors:  Steven J Russell; Mallory A Hillard; Courtney Balliro; Kendra L Magyar; Rajendranath Selagamsetty; Manasi Sinha; Kerry Grennan; Debbie Mondesir; Laya Ekhlaspour; Hui Zheng; Edward R Damiano; Firas H El-Khatib
Journal:  Lancet Diabetes Endocrinol       Date:  2016-02-03       Impact factor: 32.069

2.  The surveillance error grid.

Authors:  David C Klonoff; Courtney Lias; Robert Vigersky; William Clarke; Joan Lee Parkes; David B Sacks; M Sue Kirkman; Boris Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2014-06-13

3.  Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals.

Authors:  Fraser Cameron; Günter Niemeyer; Darrell M Wilson; B Wayne Bequette; Kari S Benassi; Paula Clinton; Bruce A Buckingham
Journal:  Diabetes Technol Ther       Date:  2014-09-26       Impact factor: 6.118

4.  "Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus.

Authors:  Youqing Wang; Jinping Zhang; Fanmao Zeng; Na Wang; Xiaoping Chen; Bo Zhang; Dong Zhao; Wenying Yang; Claudio Cobelli
Journal:  Diabetes Technol Ther       Date:  2017-01-06       Impact factor: 6.118

5.  A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes.

Authors:  Viktorija Matuleviciene; Jeffrey I Joseph; Mervi Andelin; Irl B Hirsch; Stig Attvall; Aldina Pivodic; Sofia Dahlqvist; David Klonoff; Börje Haraldsson; Marcus Lind
Journal:  Diabetes Technol Ther       Date:  2014-09-18       Impact factor: 6.118

Review 6.  Clinical review: insulin pump-associated adverse events in adults and children.

Authors:  P L Ross; J Milburn; D M Reith; E Wiltshire; B J Wheeler
Journal:  Acta Diabetol       Date:  2015-06-21       Impact factor: 4.280

7.  Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.

Authors:  P G Jacobs; J El Youssef; R Reddy; N Resalat; D Branigan; J Condon; N Preiser; K Ramsey; M Jones; C Edwards; K Kuehl; J Leitschuh; U Rajhbeharrysingh; J R Castle
Journal:  Diabetes Obes Metab       Date:  2016-08-15       Impact factor: 6.577

8.  Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs).

Authors:  Daniel P Howsmon; Faye Cameron; Nihat Baysal; Trang T Ly; Gregory P Forlenza; David M Maahs; Bruce A Buckingham; Juergen Hahn; B Wayne Bequette
Journal:  Sensors (Basel)       Date:  2017-01-15       Impact factor: 3.576

9.  Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.

Authors:  Satish K Garg; Stuart A Weinzimer; William V Tamborlane; Bruce A Buckingham; Bruce W Bode; Timothy S Bailey; Ronald L Brazg; Jacob Ilany; Robert H Slover; Stacey M Anderson; Richard M Bergenstal; Benyamin Grosman; Anirban Roy; Toni L Cordero; John Shin; Scott W Lee; Francine R Kaufman
Journal:  Diabetes Technol Ther       Date:  2017-01-30       Impact factor: 6.118

10.  Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies.

Authors:  Michael Gibney; Zhenyi Xue; Monica Swinney; Damian Bialonczyk; Laurence Hirsch
Journal:  Diabetes Technol Ther       Date:  2015-12-24       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.